Literature DB >> 12775868

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.

C E Brightling1, F A Symon, S S Birring, P Bradding, A J Wardlaw, I D Pavord.   

Abstract

BACKGROUND: Eosinophilic bronchitis is a condition characterised by a corticosteroid responsive cough, sputum eosinophilia, and normal tests of variable airflow obstruction and airway responsiveness. We performed a detailed comparative immunopathological study to test the hypothesis that the different airway function in patients with eosinophilic bronchitis and asthma reflects differences in the nature of the lower airway inflammatory response.
METHODS: Exhaled nitric oxide was measured and induced sputum, bronchoscopy, bronchial wash (BW), bronchoalveolar lavage (BAL), and bronchial biopsy were performed in 16 subjects with eosinophilic bronchitis, 15 with asthma, and 14 normal controls.
RESULTS: Both eosinophilic bronchitis and asthma were characterised by an induced sputum, BW and BAL eosinophilia, an increased number of epithelial and subepithelial eosinophils, and increased reticular basement membrane thickness. The median concentration of exhaled nitric oxide was higher in those with eosinophilic bronchitis (12 ppb) or asthma (8.5 ppb) than normal controls (2 ppb) (95% CI of the difference 5 to 16, p<0.0001 and 2 to 11.3, p=0.004, respectively). There were no group differences in epithelial integrity or the number of subepithelial T lymphocytes, mast cells or macrophages.
CONCLUSION: With the exception of our previously reported association of smooth muscle mast cell infiltration with asthma, the immunopathology of eosinophilic bronchitis and asthma are similar which suggests that eosinophilic airway inflammation, increased exhaled nitric oxide, and increased basement membrane thickening are regulated independently of airway hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775868      PMCID: PMC1746707          DOI: 10.1136/thorax.58.6.528

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  31 in total

1.  Epithelial desquamation in asthma: artifact or pathology?

Authors:  C Ordoñez; R Ferrando; D M Hyde; H H Wong; J V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

2.  Prednisone-dependent asthma: inflammatory indices in induced sputum.

Authors:  M M Pizzichini; E Pizzichini; L Clelland; A Efthimiadis; I Pavord; J Dolovich; F E Hargreave
Journal:  Eur Respir J       Date:  1999-01       Impact factor: 16.671

3.  TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

Authors:  Christopher E Brightling; Fiona A Symon; Surinder S Birring; Peter Bradding; Ian D Pavord; Andrew J Wardlaw
Journal:  J Allergy Clin Immunol       Date:  2002-12       Impact factor: 10.793

Review 4.  Eosinophils in asthma and other allergic diseases.

Authors:  A J Wardlaw; C Brightling; R Green; G Woltmann; I Pavord
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

5.  Mast-cell infiltration of airway smooth muscle in asthma.

Authors:  Christopher E Brightling; Peter Bradding; Fiona A Symon; Stephen T Holgate; Andrew J Wardlaw; Ian D Pavord
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

6.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  M J Leckie; A ten Brinke; J Khan; Z Diamant; B J O'Connor; C M Walls; A K Mathur; H C Cowley; K F Chung; R Djukanovic; T T Hansel; S T Holgate; P J Sterk; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

7.  Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.

Authors:  C E Brightling; R Ward; A J Wardlaw; I D Pavord
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

8.  Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.

Authors:  C E Brightling; W Monterio; R H Green; D Parker; M D Morgan; A J Wardlaw; D Pavord
Journal:  Respir Med       Date:  2001-12       Impact factor: 3.415

9.  A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation.

Authors:  G S Berlyne; K Parameswaran; D Kamada; A Efthimiadis; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  2000-10       Impact factor: 10.793

10.  Effect of anti-IgE therapy in patients with peanut allergy.

Authors:  Donald Y M Leung; Hugh A Sampson; John W Yunginger; A Wesley Burks; Lynda C Schneider; Cornelis H Wortel; Frances M Davis; John D Hyun; William R Shanahan
Journal:  N Engl J Med       Date:  2003-03-10       Impact factor: 91.245

View more
  55 in total

Review 1.  Non-astmatic Eosinophilic Bronchitis.

Authors:  Tekin Yıldız; Seyhan Dülger
Journal:  Turk Thorac J       Date:  2017-09-27

2.  Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1.

Authors:  Lucy Woodman; Salman Siddiqui; Glenn Cruse; Amanda Sutcliffe; Ruth Saunders; Davinder Kaur; Peter Bradding; Christopher Brightling
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

4.  Increased Sputum IL-17A Level in Non-asthmatic Eosinophilic Bronchitis.

Authors:  Chen Zhan; Rong Xu; Jiaxing Liu; Shengfang Zhang; Wei Luo; Ruchong Chen; Kefang Lai
Journal:  Lung       Date:  2018-10-01       Impact factor: 2.584

5.  Biomarker-based asthma phenotypes of corticosteroid response.

Authors:  Douglas C Cowan; D Robin Taylor; Laura E Peterson; Jan O Cowan; Rochelle Palmay; Avis Williamson; Jef Hammel; Serpil C Erzurum; Stanley L Hazen; Suzy A A Comhair
Journal:  J Allergy Clin Immunol       Date:  2014-12-06       Impact factor: 10.793

Review 6.  Exhaled nitric oxide: a test for diagnosis and control of asthma?

Authors:  Rohit Katial; Lora Stewart
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

7.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

8.  Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis.

Authors:  S Siddiqui; S Gupta; G Cruse; P Haldar; J Entwisle; S Mcdonald; P J Whithers; S V Hainsworth; H O Coxson; C Brightling
Journal:  Allergy       Date:  2009-02-11       Impact factor: 13.146

9.  Eosinophilic bronchitis, eosinophilia associated genetic variants, and notch signaling in asthma.

Authors:  Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-17       Impact factor: 5.764

10.  Dyspnea and wheezing after adenosine injection in a patient with eosinophilic bronchitis.

Authors:  Rodrigo Cartin-Ceba; Marie Christine Aubry; Kaiser Lim
Journal:  Case Rep Med       Date:  2009-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.